A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis
Status:
Completed
Trial end date:
2006-08-03
Target enrollment:
Participant gender:
Summary
This study is designed to compare a range of doses of SB-681323 with prednisolone, which has
known effects on rheumatoid arthritis patients. By comparing the two drugs and their effects
on blood proteins that indicate for rheumatoid arthritis, we hope to ascertain information on
the most effective dose of SB-681323 to use in future.